Trial Profile
Multicenter, Phase II Study of Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage ? Esophageal Squamous Cell Carcinoma Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 16 Dec 2010 New trial record